Teladoc Health, Inc. - Common Stock (TDOC)

CUSIP: 87918A105

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / Common Stock
Shares outstanding
178,397,403
Total 13F shares
127,657,050
Share change
+3,111,787
Total reported value
$1,111,810,150
Put/Call ratio
131%
Price per share
$8.71
Number of holders
348
Value change
+$28,908,039
Number of buys
150
Number of sells
179

Quarterly Holders Quick Answers

What is CUSIP 87918A105?
CUSIP 87918A105 identifies TDOC - Teladoc Health, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of TDOC - Teladoc Health, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
VANGUARD GROUP INC
13F
Company
11%
19,752,338
$157,228,611 31 Mar 2025
13F
BlackRock, Inc.
13F 13D/G
Company
7.8%
from 13D/G
14,974,084
$119,193,710 31 Mar 2025
RENAISSANCE TECHNOLOGIES LLC
13F
Company
3.7%
6,546,242
$52,108,086 31 Mar 2025
13F
Point72 Asset Management, L.P.
13F
Company
3.6%
6,509,902
$51,818,818 31 Mar 2025
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
2.8%
5,051,110
$40,207,394 31 Mar 2025
13F
STATE STREET CORP
13F
Company
2.8%
5,013,782
$39,909,705 31 Mar 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
2.3%
4,065,841
$32,371,910 31 Mar 2025
13F
Maple Rock Capital Partners Inc.
13F
Company
1.9%
3,347,340
$26,644,826 31 Mar 2025
13F
GOLDMAN SACHS GROUP INC
13F
Company
1.6%
2,859,598
$22,762,400 31 Mar 2025
13F
MORGAN STANLEY
13F
Company
1.6%
2,845,884
$22,653,252 31 Mar 2025
13F
TWO SIGMA ADVISERS, LP
13F
Company
1.6%
2,834,411
$22,561,912 31 Mar 2025
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
1.5%
2,591,339
$20,627,058 31 Mar 2025
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
1.4%
2,571,673
$20,470,517 31 Mar 2025
13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC
13F
Company
1.4%
2,476,817
$19,715,463 31 Mar 2025
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
1.4%
2,454,695
$19,539,372 31 Mar 2025
13F
AMERIPRISE FINANCIAL INC
13F
Company
1.2%
2,221,636
$17,684,218 31 Mar 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
1.1%
2,019,464
$16,074,933 31 Mar 2025
13F
NORTHERN TRUST CORP
13F
Company
0.9%
1,612,020
$12,831,679 31 Mar 2025
13F
Jason N. Gorevic
3/4/5
CHIEF EXECUTIVE OFFICER, Director
mixed-class rows
850,801
mixed-class rows
$12,481,519 19 Mar 2024
Connor, Clark & Lunn Investment Management Ltd.
13F
Company
0.87%
1,558,369
$12,404,617 31 Mar 2025
13F
Nuveen, LLC
13F
Company
0.83%
1,481,018
$11,788,903 31 Mar 2025
13F
UBS Group AG
13F
Company
0.79%
1,415,936
$11,270,850 31 Mar 2025
13F
TANG CAPITAL MANAGEMENT LLC
13F
Company
0.78%
1,400,000
$11,144,000 31 Mar 2025
13F
Invenomic Capital Management LP
13F
Company
0.74%
1,327,128
$10,563,939 31 Mar 2025
13F
JPMORGAN CHASE & CO
13F
Company
0.72%
1,278,104
$10,173,709 31 Mar 2025
13F
CITADEL ADVISORS LLC
13F
Company
0.59%
1,056,159
$8,407,026 31 Mar 2025
13F
Cubist Systematic Strategies, LLC
13F
Company
0.52%
934,299
$7,437,017 31 Mar 2025
13F
Trexquant Investment LP
13F
Company
0.51%
907,859
$7,226,558 31 Mar 2025
13F
Man Group plc
13F
Company
0.5%
885,365
$7,047,505 31 Mar 2025
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.42%
753,419
$5,997,215 31 Mar 2025
13F
D. E. Shaw & Co., Inc.
13F
Company
0.4%
708,743
$5,641,595 31 Mar 2025
13F
Robeco Institutional Asset Management B.V.
13F
Company
0.4%
705,478
$5,615,605 31 Mar 2025
13F
ORACLE INVESTMENT MANAGEMENT INC
13F
Company
0.32%
565,900
$4,504,564 31 Mar 2025
13F
Bank of New York Mellon Corp
13F
Company
0.31%
551,581
$4,390,582 31 Mar 2025
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.29%
513,456
$4,087,110 31 Mar 2025
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.29%
511,355
$4,070,386 31 Mar 2025
13F
Monaco Asset Management SAM
13F
Company
0.28%
500,000
$3,980,000 31 Mar 2025
13F
Jump Financial, LLC
13F
Company
0.28%
491,225
$3,910,151 31 Mar 2025
13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
13F
Company
0.25%
447,992
$3,566,015 31 Mar 2025
13F
BARCLAYS PLC
13F
Company
0.25%
447,578
$3,562,722 31 Mar 2025
13F
Quantinno Capital Management LP
13F
Company
0.24%
428,300
$3,409,275 31 Mar 2025
13F
NISA INVESTMENT ADVISORS, LLC
13F
Company
0.24%
425,918
$3,390,307 31 Mar 2025
13F
TCW GROUP INC
13F
Company
0.23%
418,697
$3,332,828 31 Mar 2025
13F
FEDERATED HERMES, INC.
13F
Company
0.22%
398,791
$3,174,376 31 Mar 2025
13F
AMERICAN CENTURY COMPANIES INC
13F
Company
0.21%
375,050
$2,985,398 31 Mar 2025
13F
Universal- Beteiligungs- und Servicegesellschaft mbH
13F
Individual
0.2%
359,504
$2,861,652 31 Mar 2025
13F
Qube Research & Technologies Ltd
13F
Company
0.2%
358,179
$2,851,105 31 Mar 2025
13F
VOYA INVESTMENT MANAGEMENT LLC
13F
Company
0.2%
356,230
$2,835,591 31 Mar 2025
13F
Swiss National Bank
13F
Company
0.19%
333,602
$2,655,472 31 Mar 2025
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
0.19%
332,280
$2,644,949 31 Mar 2025
13F

Institutional Holders of Teladoc Health, Inc. - Common Stock (TDOC) as of Q2 2025

As of 30 Jun 2025, Teladoc Health, Inc. - Common Stock (TDOC) was held by 348 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 127,657,050 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock, Inc., Point72 Asset Management, L.P., RENAISSANCE TECHNOLOGIES LLC, DIMENSIONAL FUND ADVISORS LP, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, WELLINGTON MANAGEMENT GROUP LLP, TWO SIGMA ADVISERS, LP, and Maple Rock Capital Partners Inc.. This page lists 351 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
368
Q2 2025 holders
348
Holder diff
-20
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 Value $ Q2 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .